脑苏冲剂治疗急性颅脑损伤的临床疗效观察

目的　观察脑苏冲剂在治疗急性颅脑损伤中的作用。方法　自 2 0 0 0年 4月～ 2 0 0 2月 4月共收治 80例急性颅脑损伤患者 ,均为轻、中型颅脑损伤。随机分成两组 :对照组 38例 ,给予一般西药治疗 ,如 2 0 %甘露醇、激素、胞二磷胆碱 ;治疗组 4 2例 ,除用上述药物外 ,加用脑苏冲剂口服。观察患者头痛、头晕、恶心、呕吐减轻与缓解的时间 ,开始排便的时间。结果　治疗组患者头痛、头晕好转及缓解的时间明显缩短 (P <0 0 1) ,恶心、呕吐缓解的时间 ,开始排便的时间明显短于对照组 (P<0 0 1)。结论　脑苏冲剂对急性颅脑损伤有良好的治疗效果。     

清开颗粒对急性肝坏死大鼠血清一氧化氮和肿瘤坏死因子的影响

目的 观察清开颗粒对大鼠血清一氧化氮（NO）及肿瘤坏死因子（TNF）的影响，探讨清开颗粒抗急性肝坏死的作用机制。方法 分别以D－GalN加LPS染毒和TAA染毒Wistar大鼠造成两种急性肝坏死动物模型。用Backman自动生化分析仪测试血清NO和TNF。结果 清开颗粒治疗组和预防组的血清NO和TNF水平明显低于模型组和HGF对照组（P＜0.05）。结论 清开颗粒有降低大鼠血清NO和TNF的作用，这可能就是清开颗粒抗急性肝坏死的作用机制之一。     

益心复脉冲剂中人参、五味子、丹参的薄层色谱研究

采用薄层色谱法对益心复脉冲剂中人参、五味子、丹参主要成分进行研究,发现药物在共煎过程中,人参皂甙发生水解转化;五味子主要成分为五味子醇甲、醇乙;丹参主要成分为丹参素、原儿茶醛。     

开郁清胃颗粒对糖尿病大鼠肝脏和骨骼肌细胞胰岛素受体的影响

研究开郁清胃颗粒对链脲佐菌素所致糖尿病大鼠肝及骨骼肌细胞膜胰岛素受体结合力及胰岛素样生长因子(IGF-1)的影响.实验大鼠分成4组:正常组,糖尿病模型组,糖尿病中药治疗组,糖尿病西药治疗组;各组分别给药1个月.结果糖尿病中药治疗组大鼠与糖尿病模型组相比,血糖水平和肝脏及肌肉细胞膜胰岛素受体结合力降低(P＜0.01或P＜0.05);胰岛素样生长因子水平升高(P＜0.001),胰岛素水平无明显变化.说明开郁清胃颗粒通过增加IGF-1的水平,减少了胰岛素受体前的抵抗,从而改善了糖尿病糖代谢紊乱.     

略论留针

留针是针灸治疗疾病过程中的一个重要环节,它是指将针刺入腧穴后使之留置于穴位内一定时间.留针与否、能否正确掌握留针的方法和留针时间的长短,直接影响临床针刺疗效.     

毫米波辐照配合固摄方冲剂对肺癌患者生活质量的影响

目的观察用毫米波穴位辐照配合固摄方冲剂治疗晚期肺癌的疗效及其对晚期肺癌患者生活质量的影响.方法采用临床对照研究,治疗组30例,予毫米波辐照加固摄方冲剂口服;对照组26例,予固摄方冲剂口服.结果治疗后治疗组与对照组相比,卡氏评分(Karnofsky评分,简称KPS)变化、主要症状变化、生活质量疗效、实验室指标变化均有明显差异,P＜0.05.结论毫米波穴位辐照配合自拟固摄方冲剂治疗晚期肺癌患者,对改善临床症状,提高生活质量,纠正癌症营养不良(恶病质)具有较好的作用.     

清淋冲剂的主要药效学研究

目的：观察清淋冲剂(萹蓄、墨麦、关木通、车前子，桅子等)的解热、利尿、抗炎和抗菌作用。方法：采用鲜酵母致热大鼠法、利尿试验、蛋清致大鼠足跖肿胀法、二甲苯致小鼠耳廓肿胀法、纸片扩散法，观察清淋冲剂对动物体温、尿量、足肿胀程度、耳廓肿胀程度及体外抑菌情况。结果：给药后大鼠体温显著下降，尿量显著增加，大鼠足跖肿胀和小鼠耳廓肿胀显著减轻，大肠杆菌、绿脓杆菌、变形杆菌、产气杆菌、淋球菌及金黄色葡萄球菌抑菌环显著增大。结论；清淋冲刑具有明显的清热、利尿、抗炎作用，并有一定抗菌作用。     

Long-Term Clinical Effect of Tangyiping Granules(糖异平颗粒)on Patients with Impaired Glucose Tolerance

Objective: To evaluate the long-term clinical effect of Tangyiping Granules(糖异平颗粒, TYP) on patients with impaired glucose tolerance(IGT) to achieve normal glucose tolerance(NGT) and hence preventing them from conversion to diabetes mellitus(DM). Methods: In total, 127 participants with IGT were randomly assigned to the control(63 cases, 3 lost to follow-up) and treatment groups(64 cases, 4 lost to follow-up) according to the random number table. The control group received lifestyle intervention alone, while the patients in the treatment group took orally 10 g of TYP twice daily in addition to lifestyle intervention for 12 weeks. The rates of patients achieving NGT or experiencing conversion to DM as main outcome measure were observed at 3, 12, and 24 months after TYP treatment. The secondary outcome measures included fasting plasma glucose(FPG), 2-h postprandial plasma glucose(2h PG), glycosylated hemoglobin(Hb A1c), fasting insulin(FINS), 2-h insulin(2hI NS), homeostatic model assessment of insulin resistance(HOMA-IR), blood lipid and patients' complains of Chinese medicine(CM) symptoms before and after treatment. Results: A higher proportion of the treatment group achieved NGT compared with the control group after 3-, 12- and 24-month follow-up(75.00% vs. 43.33%, 58.33% vs. 35.00%, 46.67% vs. 26.67%, respectively, P0.05). The IGT to DM conversion rate of the treatment group was significantly lower than that of the control group at the end of 24-month follow-up(16.67% vs. 31.67%, P0.05). Before treatment, FPG, 2h PG, Hb A1 c, FINS, 2h INS, HOMA-IR, triglyceride(TG), total cholesterol, low- and high-density lipoprotein cholesterol levels had no statistical difference between the two groups(P0.05). After treatment, the 2hP G, HbA 1c, HOMA-IR, and TG levels of the treatment group decreased significantly compared with those of the control group(P0.05). CM symptoms such as exhaustion, irritability, chest tightness and breathless, spontaneous sweating, constipation, and dark thick and greasy tongue were significantly improved in the treatment group as compared with the control group(P0.05). No severe adverse events occurred. Conclusion: TYP administered at the IGT stage with a disciplined lifestyle delayed IGT developing into type 2 DM.     

正交试验法优选冠舒颗粒提取工艺

目的：优选冠舒颗粒的醇提工艺和水提工艺。方法采用单因素考察法和 L9（34）正交试验法,以总皂苷含量为考察指标,考察乙醇浓度、加醇量、提取时间、提取次数对醇提工艺的影响。以总多糖含量为考察指标,考察提取时间、提取次数、加水量对水提工艺的影响。结果最佳醇提工艺为加8倍于药材量70%乙醇提取3次,每次2 h;最佳水提工艺为加6倍于药材量水提取3次,每次2 h。结论冠舒颗粒提取工艺稳定可行,适合大工业生产。     

抗疏健骨颗粒治疗原发性骨质疏松症40例

目的:观察抗疏健骨颗粒治疗原发性骨质疏松症的疗效。方法:将80例原发性骨质疏松症患者随机分为治疗组和对照组,各40例。治疗组给予抗疏健骨颗粒和阿仑磷酸钠治疗,对照组给予仙灵骨葆胶囊和阿仑磷酸钠治疗。结果:两组治疗后骨密度比较,差异无统计学意义(P0.05);两组治疗后中医症状评分比较,差异无统计学意义(P0.05);治疗组治疗后血清碱性磷酸酶、血清骨钙素改善情况均优于对照组(P0.05)。结论:抗疏健骨颗粒治疗原发性骨质疏松症疗效确切。